President, Co-Founder

Over 20 years experience in big pharma, managed budgets exceeding $100 million

Led successful product launches resulting in billion-dollar growth

Founder and board member of multiple startups

Responsible for global strategy, business development, sales, marketing, and commercial operations

CSO, Co-Founder

Fellow of American Association of Pharmaceutical Scientists (AAPS)

Over 18 years experience in drug formulation development, particularly advancing nanotechnologies for cancer therapy

Key technology inventor with multiple patents

Professor at the University of Connecticut

Served as Chair of the Faculty at the National Institute for Pharmaceutical Technology and Education

Presently holds the mantle of Associate Director at the Center for Pharmaceutical Processing Research, concurrently serving as a leader in the AAPS Nanotechnology Community

CPO, Co-Founder

Over 40 years experience in drug development, imaging agents, and radiopharmaceuticals

Former director of an FDA-registered cGMP facility

Founded five companies; one obtained IND for clinical trials

Professor emeritus at the University of North Carolina at Chapel Hill

Head of R&D

More than 30 years of experience in radiopharmaceuticals, formulation, CMC, GMP, and IND filing

Former Director of Bio pharmaceuticals and Director of Product Life Extension at GSK

Managing member of BioCeutics LLC

Clinical Advisor

Medical Director, Hartford HealthCare Cancer Institute at Hartford Hospital

More than 40 years clinical experience in Radiation Oncology

American Cancer Society George Sheehan Humanitarian Award

Lane Adams Quality of Life Award

Clinical Advisor

Clinical Professor at the UCLA School of Medicine and a Fellow of the American College of Obstetricians and Gynecologists  

A pioneer in telemedicine and tele-health with more than 30 years of experience

Business Advisor

Partner at KASTx Ventures, Co-founder of TSP Therapeutics

Over 25 years in the bio/pharmaceutical industry across small to large companies

Worked in over 15 countries, leading both mature and start-up businesses across numerous therapeutic areas spanning rare diseases, oncology, primary and specialty care

Business Advisor

Founder, President, and CEO of TSP Therapeutics, Inc.

Nearly 40 years of experience as a leader in the bio/pharmaceutical industry working on nearly all sizes of business across 10 therapeutic areas, including four in the Oncology space

Conceptualizing and executing market shaping innovations

Radiopharmaceutical

More than 25 years of experience in radiochemistry and radiopharmacy of imaging agents, including Chemistry, Manufacturing and Controls, Pharmacology and Toxicology sections of IND’s ANDA’s and DMF’s, covering agents as well as other metabolic imaging agents

CMC

Served on URI faculty in pharmaceutical science, chemical engineering, and neuroscience

Senior scientist, project manager, group leader, and principal investigator at BMS, Alcinous Pharmaceuticals, and Yaupon Therapeutics

Toxicologist

Highly qualified and experienced Board-Certified Toxicologist

Fellow of the Royal Society of Biology (FRSB)

Over 30 years of experience in the pharmaceutical/biotechnology industry

Held leadership positions at Searle/Pfizer, Indivior, Epizyme, and Viridan Therapeutics

Early Clinical Development

Experience in development of companion diagnostics and early clinical development programs including regulatory filing

Project Leader/Program Director on multiple pre-clinical oncology programs which advanced into development of were successfully partnered externally